FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Resources - All Kinds

262,381 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

By Authority

By Realm

 

Start Prev Rows 153000 - 153200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthUsage #
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Invoice.lin.pri.code.jsonR4: Code identifying the specific component (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Invoice.lin.pri.factor.jsonR4: Factor used for calculating this component (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Invoice.lin.pri.type.jsonR4: base | surcharge | deduction | discount | tax | informational (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Invoice.lin.priceComponent.jsonR4: priceComponenttrial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Invoice.lineItem.jsonR4: Line items of this Invoice (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Invoice.note.jsonR4: Comments made about the invoice (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Invoice.participant.jsonR4: Participant in creation of this Invoice (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Invoice.paymentTerms.jsonR4: Payment details (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Invoice.recipient.jsonR4: Recipient of this invoice (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Invoice.status.jsonR4: draft | issued | balanced | cancelled | entered-in-error (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Invoice.totalGross.jsonR4: Gross total of this Invoice (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Invoice.totalNet.jsonR4: Net total of this Invoice (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Invoice.type.jsonR4: Type of Invoice (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Library.author.jsonR4: Who authored the content additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Library.editor.jsonR4: Who edited the content additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Library.endorser.jsonR4: Who endorsed the content additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Library.reviewer.jsonR4: Who reviewed the content additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Library.subject.jsonR4: Type of individual the library content is focused on (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Library.subtitle.jsonR4: Subordinate title of the library (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Location.availabilityExceptions.jsonR4: Description of availability exceptions (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Location.hou.allDay.jsonR4: The Location is open all day additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Location.hou.closingTime.jsonR4: Time that the Location closes (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Location.hou.daysOfWeek.jsonR4: mon | tue | wed | thu | fri | sat | sun additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Location.hou.openingTime.jsonR4: Time that the Location opens (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Location.hoursOfOperation.jsonR4: What days/times during a week is this location usually open (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Location.telecom.jsonR4: Contact details of the location (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MarketingStatus.country.jsonR4: The country in which the marketing authorisation has been granted shall be specified It should be specified using the ISO 3166 ‑ 1 alpha-2 code elements (new)trial-use0fhir2026-03uvhl7
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MarketingStatus.dateRange.jsonR4: The date when the Medicinal Product is placed on the market by the Marketing Authorisation Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain (new)trial-use0fhir2026-03uvhl7
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MarketingStatus.jurisdiction.jsonR4: Where a Medicines Regulatory Agency has granted a marketing authorisation for which specific provisions within a jurisdiction apply, the jurisdiction can be specified using an appropriate controlled terminology The controlled term and the controlled term identifier shall be specified (new)trial-use0fhir2026-03uvhl7
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MarketingStatus.restoreDate.jsonR4: The date when the Medicinal Product is placed on the market by the Marketing Authorisation Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain (new)trial-use0fhir2026-03uvhl7
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MarketingStatus.status.jsonR4: This attribute provides information on the status of the marketing of the medicinal product See ISO/TS 20443 for more information and examples (new)trial-use0fhir2026-03uvhl7
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Measure.author.jsonR4: Who authored the content additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Measure.editor.jsonR4: Who edited the content additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Measure.endorser.jsonR4: Who endorsed the content additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Measure.gro.code.jsonR4: Meaning of the group additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Measure.gro.str.code.jsonR4: Meaning of the stratifier additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Measure.gro.str.component.jsonR4: Stratifier criteria component for the measure (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Measure.gro.str.description.jsonR4: The human readable description of this stratifier (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Measure.improvementNotation.jsonR4: increase | decrease additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Measure.library.jsonR4: library additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Measure.reviewer.jsonR4: Who reviewed the content additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Measure.subject.jsonR4: E.g. Patient, Practitioner, RelatedPerson, Organization, Location, Device (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Measure.subtitle.jsonR4: Subordinate title of the measure (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Measure.sup.code.jsonR4: Meaning of the supplemental data additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Measure.sup.description.jsonR4: The human readable description of this supplemental data (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MeasureReport.gro.code.jsonR4: Meaning of the group additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MeasureReport.gro.measureScore.jsonR4: measureScore additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MeasureReport.gro.str.code.jsonR4: code additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MeasureReport.gro.str.str.component.jsonR4: Stratifier component values (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MeasureReport.gro.str.str.measureScore.jsonR4: measureScore additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MeasureReport.gro.str.str.value.jsonR4: value additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MeasureReport.improvementNotation.jsonR4: increase | decrease (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MeasureReport.measure.jsonR4: What measure was calculated additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MeasureReport.type.jsonR4: individual | subject-list | summary | data-collectiontrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Media.created.jsonR4: When Media was collected (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Media.deviceName.jsonR4: Name of the device/manufacturer (new)trial-use0fhir2026-03uvhl73
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Media.device.jsonR4: Observing Device (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Media.duration.jsonR4: Length in seconds (audio / video) (new)trial-use0fhir2026-03uvhl73
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Media.encounter.jsonR4: Encounter associated with media (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Media.frames.jsonR4: Number of frames if > 1 (photo) (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Media.height.jsonR4: Height of the image in pixels (photo/video) (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Media.issued.jsonR4: Date/Time this version was made available (new)trial-use0fhir2026-03uvhl73
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Media.note.jsonR4: Comments made about the media (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Media.operator.jsonR4: The person who generated the image (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Media.partOf.jsonR4: Part of referenced event (new)trial-use0fhir2026-03uvhl73
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Media.reasonCode.jsonR4: Why was event performed? (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Media.status.jsonR4: preparation | in-progress | not-done | on-hold | stopped | completed | entered-in-error | unknown (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Media.type.jsonR4: Classification of media as image, video, or audio additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Media.view.jsonR4: Imaging view, e.g. Lateral or Antero-posterior (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Media.width.jsonR4: Width of the image in pixels (photo/video) (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Medication.amount.jsonR4: Amount of drug in package (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Medication.batch.jsonR4: Details about packaged medications (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-Medication.identifier.jsonR4: Business identifier for this medication (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-Medication.ing.item.jsonR4: The actual ingredient or content additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationAdministration.effective.jsonR4: Start and end time of administration (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationAdministration.instantiates.jsonR4: Instantiates protocol or definition (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MA.per.actor.jsonR4: Who performed the medication administration additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MA.per.function.jsonR4: Type of performance (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationAdministration.reasonReference.jsonR4: Condition or observation that supports why the medication was administered additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationAdministration.statusReason.jsonR4: Reason administration not performed (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationAdministration.status.jsonR4: in-progress | not-done | on-hold | completed | entered-in-error | stopped | unknown additional codestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationDispense.detectedIssue.jsonR4: Clinical issue with action (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationDispense.per.function.jsonR4: Who performed the dispense and what they did (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationDispense.statusReason.jsonR4: Why a dispense was not performed (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationDispense.status.jsonR4: preparation | in-progress | cancelled | on-hold | completed | entered-in-error | stopped | declined | unknown additional codestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.adm.indication.jsonR4: Indication for use that apply to the specific administration guidelines (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.adm.pat.characteristic.jsonR4: Specific characteristic that is relevant to the administration guideline (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.adm.pat.value.jsonR4: The specific characteristic (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.administrationGuidelines.jsonR4: Guidelines for administration of the medication (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.amount.jsonR4: Amount of drug in package (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.associatedMedication.jsonR4: A medication resource that is associated with this medication (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.code.jsonR4: Code that identifies this medication (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.contraindication.jsonR4: Potential clinical issue with or between medication(s) (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.cost.jsonR4: The pricing of the medication (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.doseForm.jsonR4: powder | tablets | capsule + (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.dru.value.jsonR4: Description of the characteristic (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.drugCharacteristic.jsonR4: Specifies descriptive properties of the medicine (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.ingredient.jsonR4: Active or inactive ingredient (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.intendedRoute.jsonR4: The intended or approved route of administration (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.kinetics.jsonR4: The time course of drug absorption, distribution, metabolism and excretion of a medication from the body (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.manufacturer.jsonR4: Manufacturer of the item (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.medicineClassification.jsonR4: Categorization of the medication within a formulary or classification system (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.monitoringProgram.jsonR4: Program under which a medication is reviewed (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.monograph.jsonR4: Associated documentation about the medication (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.pac.quantity.jsonR4: The number of product units the package would contain if fully loaded (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.pac.type.jsonR4: A code that defines the specific type of packaging that the medication can be found in (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.packaging.jsonR4: Details about packaged medications (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.preparationInstruction.jsonR4: The instructions for preparing the medication (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.productType.jsonR4: Category of the medication or product (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.reg.sch.schedule.jsonR4: Specifies the specific drug schedule (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.regulatory.jsonR4: Regulatory information about a medication (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.rMK.jsonR4: Associated or related medication information (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationKnowledge.synonym.jsonR4: Additional names for a medication (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.courseOfTherapyType.jsonR4: Overall pattern of medication administration (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.detectedIssue.jsonR4: Clinical Issue with action (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.dis.dispenseInterval.jsonR4: Minimum period of time between dispenses (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.dis.initialFill.jsonR4: First fill details (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.dis.nORA.jsonR4: numberOfRepeatsAllowed additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.doNotPerform.jsonR4: True if request is prohibiting action (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.instantiatesCanonical.jsonR4: Instantiates FHIR protocol or definition (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.instantiatesUri.jsonR4: Instantiates external protocol or definition (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.insurance.jsonR4: Associated insurance coverage (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.intent.jsonR4: proposal | plan | order | original-order | reflex-order | filler-order | instance-order | optiontrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.performerType.jsonR4: Desired kind of performer of the medication administration (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.performer.jsonR4: Intended performer of administration (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.reasonReference.jsonR4: Condition or observation that supports why the prescription is being written additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.reported.jsonR4: Reported rather than primary record additional typestrial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.statusReason.jsonR4: Reason for current status (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.status.jsonR4: active | on-hold | cancelled | completed | entered-in-error | stopped | draft | unknown additional codestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicationRequest.sub.allowed.jsonR4: Whether substitution is allowed or not additional typestrial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationStatement.reasonCode.jsonR4: Reason for why the medication is being/was taken (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationStatement.reasonReference.jsonR4: Condition or observation that supports why the medication is being/was taken (new)trial-use0fhir2026-03uvhl71
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationStatement.statusReason.jsonR4: Reason for current status (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r5R5StructureDefinition/StructureDefinition-ext-R4-MedicationStatement.status.jsonR4: active | completed | entered-in-error | intended | stopped | on-hold | unknown | not-takentrial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.aMI.jsonR4: Whether the Medicinal Product is subject to additional monitoring for regulatory reasons (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.attachedDocument.jsonR4: Supporting documentation, typically for regulatory submission (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.clinicalTrial.jsonR4: Clinical trials or studies that this product is involved in (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.cPDF.jsonR4: The dose form for a single part product, or combined form of a multiple part product (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.contact.jsonR4: A product specific contact, person (in a role), or an organization (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.crossReference.jsonR4: Reference to another product, e.g. for linking authorised to investigational product (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.domain.jsonR4: If this medicine applies to human or veterinary uses (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.legalStatusOfSupply.jsonR4: The legal status of supply of the medicinal product as classified by the regulator (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.mBO.jsonR4: An operation applied to the product, for manufacturing or adminsitrative purpose (new)trial-use0fhir2026-03uvhl75
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.marketingStatus.jsonR4: Marketing status of the medicinal product, in contrast to marketing authorizaton (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.masterFile.jsonR4: A master file for to the medicinal product (e.g. Pharmacovigilance System Master File) (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.name.jsonR4: The product's name, including full name and possibly coded parts (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.packagedMedicinalProduct.jsonR4: Package representation for the product additional typestrial-use0fhir2026-03uvhl75
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.paediatricUseIndicator.jsonR4: If authorised for use in children (new)trial-use0fhir2026-03uvhl75
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.pharmaceuticalProduct.jsonR4: Pharmaceutical aspects of product (new)trial-use0fhir2026-03uvhl75
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.productClassification.jsonR4: Allows the product to be classified by various systems (new)trial-use0fhir2026-03uvhl75
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.specialDesignation.jsonR4: Indicates if the medicinal product has an orphan designation for the treatment of a rare disease (new)trial-use0fhir2026-03uvhl75
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.specialMeasures.jsonR4: specialMeasures additional typestrial-use0fhir2026-03uvhl75
hl7.fhir.uv.xver-r4.r3R3StructureDefinition/StructureDefinition-ext-R4-MedicinalProduct.type.jsonR4: Regulatory type, e.g. Investigational or Authorized (new)trial-use0fhir2026-03uvhl72
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.country.jsonR4: The country in which the marketing authorization has been granted (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MPA.dEP.jsonR4: A period of time after authorization before generic product applicatiosn can be submitted (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MPA.dOFA.jsonR4: The date when the first authorization was granted by a Medicines Regulatory Agency (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.holder.jsonR4: Marketing Authorization Holder (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MPA.iBD.jsonR4: Date of first marketing authorization for a company's new medicinal product in any country in the World (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.jurisdiction.jsonR4: Jurisdiction within a country (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MPA.jA.jsonR4: Authorization in areas within a country (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.legalBasis.jsonR4: The legal framework against which this authorization is granted (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.procedure.jsonR4: The regulatory procedure for granting or amending a marketing authorization (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.regulator.jsonR4: Medicines Regulatory Agency (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.restoreDate.jsonR4: The date when a suspended the marketing or the marketing authorization of the product is anticipated to be restored (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.statusDate.jsonR4: The date at which the given status has become applicable (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.status.jsonR4: The status of the marketing authorization (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductAuthorization.validityPeriod.jsonR4: The beginning of the time period in which the marketing authorization is in the specific status shall be specified A complete date consisting of day, month and year shall be specified using the ISO 8601 date format (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductContraindication.comorbidity.jsonR4: A comorbidity (concurrent condition) or coinfection (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MPC.diseaseStatus.jsonR4: The status of the disease or symptom for the contraindication (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductContraindication.disease.jsonR4: The disease, symptom or procedure for the contraindication (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductContraindication.otherTherapy.jsonR4: Information about the use of the medicinal product in relation to other therapies described as part of the indication (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductContraindication.population.jsonR4: The population group to which this applies (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MPC.tI.jsonR4: Information about the use of the medicinal product in relation to other therapies as part of the indication (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductIndication.comorbidity.jsonR4: Comorbidity (concurrent condition) or co-infection as part of the indication (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductIndication.diseaseStatus.jsonR4: The status of the disease or symptom for which the indication applies (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MPI.dSP.jsonR4: The disease, symptom or procedure that is the indication for treatment (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductIndication.duration.jsonR4: Timing or duration information as part of the indication (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductIndication.intendedEffect.jsonR4: The intended effect, aim or strategy to be achieved by the indication (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductIndication.otherTherapy.jsonR4: Information about the use of the medicinal product in relation to other therapies described as part of the indication (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductIndication.population.jsonR4: The population group to which this applies (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductIndication.undesirableEffect.jsonR4: Describe the undesirable effects of the medicinal product (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MPI.allergenicIndicator.jsonR4: If the ingredient is a known or suspected allergen (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductIngredient.manufacturer.jsonR4: Manufacturer of this Ingredient (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductIngredient.role.jsonR4: Ingredient role e.g. Active ingredient, excipient (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MPI.spe.strength.jsonR4: Quantity of the substance or specified substance present in the manufactured item or pharmaceutical product (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductIngredient.specifiedSubstance.jsonR4: A specified substance that comprises this ingredient (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductIngredient.substance.jsonR4: The ingredient substance (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductInteraction.description.jsonR4: The interaction described (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductInteraction.effect.jsonR4: The effect of the interaction, for example "reduced gastric absorption of primary medication" (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductInteraction.incidence.jsonR4: The incidence of the interaction, e.g. theoretical, observed (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductInteraction.interactant.jsonR4: The specific medication, food or laboratory test that interacts (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductInteraction.management.jsonR4: Actions for managing the interaction (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductInteraction.type.jsonR4: The type of the interaction e.g. drug-drug interaction, drug-food interaction, drug-lab test interaction (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductManufactured.ingredient.jsonR4: Ingredient (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MPM.manufacturedDoseForm.jsonR4: Dose form as manufactured and before any transformation into the pharmaceutical product (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductManufactured.manufacturer.jsonR4: Manufacturer of the item (Note that this should be named "manufacturer" but it currently causes technical issues) (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MPM.otherCharacteristics.jsonR4: Other codeable characteristics (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MPM.pC.jsonR4: Dimensions, color etc. (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MedicinalProductManufactured.quantity.jsonR4: The quantity or "count number" of the manufactured item (new)trial-use0fhir2026-03uvhl74
hl7.fhir.uv.xver-r4.r4bR4BStructureDefinition/StructureDefinition-ext-R4-MPM.unitOfPresentation.jsonR4: The “real world” units in which the quantity of the manufactured item is described (new)trial-use0fhir2026-03uvhl74